Juan W Valle, Chief Medical Officer at Cholangiocarcinoma Foundation, shared a post on LinkedIn:
“Today marks the first Cancer Biomarkers Awareness Day, a timely opportunity to consider how biomarker testing is transforming cancer care and providing clinicians with critical insights that help match patients with therapies most likely to be effective for their specific cancer.
However, we must do more to ensure that testing occurs early and equitably. Every patient deserves access to biomarker testing before treatment begins.
The Cholangiocarcinoma Foundation is proud to collaborate through the Cancer Precision Medicine Commons, where leaders across cancer types come together to share knowledge and explore opportunities to advance precision oncology.
We move forward by connecting communities, educating clinicians, and empowering patients to ask for timely testing.
More posts featuring Juan W Valle.